Trending:
FDA panel backs first-of-its-kind flu vaccine using mRNA technology | Times News Online

WASHINGTON — A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the COVID-19 pandemic.The Food and Drug Administration is evaluating Moderna’s new shot, d...

Bhutan Observer
Bhutan Observer

www.bhutanobserver.bt